Vitamin C potentiates the killing of Mycobacterium tuberculosis by bedaquiline through metabolic disruption
ABSTRACT Tuberculosis (TB), a disease caused by the bacterium Mycobacterium tuberculosis (Mtb), continues to pose a major global health threat, exacerbated by the emergence of drug-resistant strains and the lengthy treatment regimens required for effective management. Bedaquiline (BDQ), a key compon...
Saved in:
| Main Authors: | Catherine Vilchèze, Saranathan Rajagopalan, Raja Sab Kalluru, Niaz Banaei, William R. Jacobs |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society for Microbiology
2025-08-01
|
| Series: | mBio |
| Subjects: | |
| Online Access: | https://journals.asm.org/doi/10.1128/mbio.01484-25 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bedaquiline resistance in Mycobacterium tuberculosis during antimycobacterial therapy and its impact on clinical outcomes (clinical cases)
by: O. M. Raznatovska, et al.
Published: (2023-03-01) -
Bedaquiline practice in treatment of extensively drug-resistant mycobacterium tuberculosis in children: Clinical cases
by: A. A. Akzhigitova, et al.
Published: (2022-05-01) -
Distribution of Minimum Inhibitory Concentrations and Resistance-associated Gene Mutations in Multidrug-resistant Mycobacterium tuberculosis Strains from Southern Türkiye: Insights on Bedaquiline, Delamanid, and Linezolid
by: Huda Ahmed, et al.
Published: (2024-12-01) -
Curcumin enhances bedaquiline’s efficacy against Mycobacterium abscessus: in vitro and in vivo evidence
by: Dan Luo, et al.
Published: (2025-05-01) -
Prevalence of bedaquiline resistance in patients with drug-resistant tuberculosis: a systematic review and meta-analysis
by: Xinyang Hu, et al.
Published: (2025-05-01)